Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 547 of 6351
-
New drug combo aims to keep bladder cancer from coming back
Disease control Recruiting nowThe purpose of this study is to learn about the safety and effects of the study medicine (Disitamab Vedotin) in people with non-muscle invasive bladder cancer. This study is seeking participants whose bladder cancer is still in early stages, has not spread outside of the bladder,…
Phase 3 • Sponsor: Fudan University • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New cell therapy aims to make mismatched donor transplants safer for blood cancer patients
Disease control Recruiting nowThe study goal is to characterize the safety of the combination of Orca-T with dual agent GVHD prophylaxis.
Phase 1 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New protocol aims to halve deadly rearrests after cardiac arrest
Disease control Recruiting nowOut-of-hospital cardiac arrest (OHCA) remains a leading global emergency condition with low survival to hospital discharge despite advances in cardiopulmonary resuscitation. Return of spontaneous circulation (ROSC) rates have improved; however, 30-50% of patients experience rearr…
Phase 2/3 • Sponsor: Siriraj Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug BB102 takes on Hard-to-Treat liver cancer
Disease control Not yet recruitingThis is a Phase 2 study to evaluate the efficacy and safety of BB102, a highly selective and potent FGFR4 inhibitor, as monotherapy in subjects with advanced or unresectable FGF19-overexpressing hepatocellular carcinoma. This study has two phase: dose escalation phase and expansi…
Phase 2 • Sponsor: Broadenbio Ltd., Co. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Can timing of infusion beat liver cancer recurrence?
Disease control Recruiting nowStudy on the therapeutic effect of different infusion times on tislelizumab in high-risk postoperative hepatocellular carcinoma
Sponsor: Sir Run Run Shaw Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
AI eye test could spot Alzheimer's early
Diagnosis Not yet recruitingThe purpose of this study is to test the use of a screening tool to detect changes in the eye that are associated with Alzheimer's disease in adult participants with memory issues. For each participant, the study will last up to one month and requires one visit to the research si…
Sponsor: Eli Lilly and Company • Aim: Diagnosis
Last updated Jun 27, 2026 08:00 UTC
-
Poop pills take on superbugs in new clinical trial
Disease control Not yet recruitingThe aim of the study is to see whether fecal microbiota transplantation is effective to decolonize multidrug-resistant organisms.
Sponsor: Kyungpook National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Can a pregnancy vaccine shield newborns from RSV? new study investigates
Vaccine OngoingTo generate critical evidence to support vaccine policy and implementation, Pfizer will collaborate with Kaiser Permanente Northern California (KPNC) to study the vaccine effectiveness (VE) of ABRYSVO vaccination during pregnancy in a real-world population. The overall research q…
Sponsor: Pfizer • Aim: Vaccine
Last updated Jun 27, 2026 13:08 UTC
-
Engineered immune cells take on lupus and kidney disease in new trial
Disease control Recruiting nowCAR T-cell Therapy Targeting CD19 and BCMA in Patients With B cell mediated autoimmune disease.
Phase 1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New hope for teens with rare obesity: weekly shot shows promise
Disease control Recruiting nowThis observational study aims to assess the effect of once-weekly s.c. semaglutide 2.4 mg as an adjunct to a calorie-reduced diet and increased physical activity on weight loss, change in hunger, body composition, depression, and quality of life after 68 weeks of treatment in ado…
Sponsor: Prof. Dr. Martin Wabitsch • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New targeted drug shows promise for Hard-to-Treat gynecologic cancers
Disease control Not yet recruitingThis study is a single-arm, open-label, multicenter Phase IIa trial designed to evaluate the efficacy, safety, and pharmacokinetic profile of BRY812 for Injection in patients with LIV-1-positive advanced gynecological malignancies. The study comprises two cohorts. For Cohort 1 (o…
Phase 2 • Sponsor: BioRay Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Could your own immune cells fight advanced cancer? new trial aims to find out
Disease control Not yet recruitingThe autologous immune cell induction technology used in this project involves transforming peripheral blood mononuclear cells (PBMC) into autologous DC cells, NK cells, CIK cells and other immune cells through cytokine induction, and then re-administering them to the patients. Th…
Phase 1/2 • Sponsor: Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New drug duo aims to shrink lung tumors before surgery
Disease control Not yet recruitingThis is a prospective, single-arm, multi-center Phase II clinical trial designed to evaluate the efficacy and safety of neoadjuvant therapy with SHR-A1811 in combination with Adebelimumab in patients with resectable, early-stage non-small cell lung cancer (NSCLC) harboring HER2 a…
Phase 2 • Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New ventilator method may save fragile preemies from breathing tubes
Disease control Recruiting nowMany extremely premature infants require immediate help with breathing after birth. Positive pressure ventilation (PPV) using a device called a T-piece resuscitator is a common method. PPV is needed to establish proper lung function, improve gas exchange, and encourage the infant…
Sponsor: Michelle Baczynski • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New device seals Stroke-Causing heart pouch during bypass surgery
Disease control Recruiting nowAtrial fibrillation is a common heart rhythm disorder that increases the risk of stroke. In patients with atrial fibrillation, blood clots most often form in a small structure of the heart called the left atrial appendage. If a blood clot travels from the heart to the brain, it c…
Sponsor: Institute of Cardiovascular Diseases, Vojvodina • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New hope for stomach cancer patients when immunotherapy fails
Disease control Recruiting nowImmunotherapy has established the new standard for first-line treatment of advanced or metastatic gastric cancer. However, current second-line options-predominantly consisting of targeted therapy plus chemotherapy or chemotherapy alone-confer only modest clinical benefit. Notably…
Phase 2 • Sponsor: Dai, Guanghai • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
AI eye in the scope: new tool aims to catch stomach cancer earlier
Diagnosis OngoingGastric cancer remains the 5th most common cancers worldwide. It also ranked 5th in the cancer related mortality, causing more than 650'000 deaths per year. Survival of gastric cancer is directly related to the stage of the presentation, with early stage cancers having a signific…
Sponsor: Chinese University of Hong Kong • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC
-
Heart failure hope for kids: diabetes drug tested as new therapy
Disease control Recruiting nowthe study to investigate the efficacy of empagiflozin in pediatric heart failure
Phase 2 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Can a smartphone app soothe pain and shield new mothers from depression?
Prevention Recruiting nowThis phase I clinical trial tests the feasibility and safety of a self-guided, mobile mindfulness-based intervention to reduce post-cesarean pain and prevent postpartum depression.
Sponsor: University of Illinois at Urbana-Champaign • Aim: Prevention
Last updated Aug 08, 2026 00:03 UTC
-
Can a classroom program heal trauma in teens?
Symptom relief Recruiting nowThis study will evaluate whether a school-based counseling program, Cognitive Behavioral Intervention for Trauma in Schools (CBITS), helps reduce trauma-related symptoms and improve psychological functioning in adolescents in Pakistan who have experienced traumatic events. Studen…
Sponsor: National University of Modern Languages • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC